申请人:HELSINN HEALTHCARE SA
公开号:US20170145038A1
公开(公告)日:2017-05-25
Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the ghrelin receptor. The compounds have the general Formula I:
or pharmaceutically acceptable salts thereof.